Lv2
170 积分 2023-02-07 加入
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe
1小时前
已完结
Synthesis of 2-(3-aminopropyl)benzopyrans as potential antipsychotic agents targeting D2/D3 and 5-HT2A receptors
3天前
已完结
Effect of TAAR1 Knockout on Behavior Characteristics of Mice in Tests Assessing Anxiety and Depressive-Like Behavior
1个月前
已完结
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
2个月前
已完结
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands
2个月前
已完结
Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019
3个月前
已完结
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
3个月前
已完结
An Updated Review on Glycoprotein IIb/IIIa Inhibitors as Antiplatelet Agents: Basic and Clinical Perspectives
3个月前
已完结
Newly identified structures of trace-amine associated receptor-1 (TAAR1) will aid discovery of next generation neuropsychiatric drugs
4个月前
已完结
Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update
5个月前
已完结
皖公网安备34019202002308
